Biotechnology M&A in 2024: What to expect
2023 brought both opportunities and challenges for the biotech industry, with mergers and acquisitions (M&As) dominating headlines due to economic pressures and regulatory changes. As we look towards 2024, experts predict that the M&A trend will continue, with deals totaling $225 billion to $275 billion, according to a PwC report. The Federal Trade Commission’s (FTC) […]